| Nina Yang, MD | |
|
115 Ne May Ln, Mcminnville, OR 97128-9272 | |
| (503) 472-1338 | |
| (503) 434-8597 |
| Full Name | Nina Yang |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 115 Ne May Ln, Mcminnville, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639465271 | NPI | - | NPPES |
| 500673100 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD166445 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Northwest | 5799688230 | 1482 |
News Archive
A team of Australian scientists has discovered a new type of cell in the immune system. The new cell type, a kind of white blood cell, belongs to a family of T-cells that play a critical role in protection against infectious disease.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
Animals that reproduce asexually by somatic cloning have special mechanisms that delay ageing provide exceptionally good health. Scientists at the University of Gothenburg have shown how colony-forming ascidians can activate the enzyme telomerase, which protects DNA. This enzyme is more active also in humans who attain an advanced age.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced today that the University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated cancer center in Baltimore, now offers the Calypso® System to provide accurate, precise, real-time tumor tracking for cancer patients undergoing external beam radiation therapy.
› Verified 7 days ago
| Entity Name | Virginia Garcia Memorial Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679528012 PECOS PAC ID: 7113823881 Enrollment ID: O20031211000992 |
News Archive
A team of Australian scientists has discovered a new type of cell in the immune system. The new cell type, a kind of white blood cell, belongs to a family of T-cells that play a critical role in protection against infectious disease.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
Animals that reproduce asexually by somatic cloning have special mechanisms that delay ageing provide exceptionally good health. Scientists at the University of Gothenburg have shown how colony-forming ascidians can activate the enzyme telomerase, which protects DNA. This enzyme is more active also in humans who attain an advanced age.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced today that the University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated cancer center in Baltimore, now offers the Calypso® System to provide accurate, precise, real-time tumor tracking for cancer patients undergoing external beam radiation therapy.
› Verified 7 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Northwest |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184786527 PECOS PAC ID: 5799688230 Enrollment ID: O20040130000799 |
News Archive
A team of Australian scientists has discovered a new type of cell in the immune system. The new cell type, a kind of white blood cell, belongs to a family of T-cells that play a critical role in protection against infectious disease.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
Animals that reproduce asexually by somatic cloning have special mechanisms that delay ageing provide exceptionally good health. Scientists at the University of Gothenburg have shown how colony-forming ascidians can activate the enzyme telomerase, which protects DNA. This enzyme is more active also in humans who attain an advanced age.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced today that the University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated cancer center in Baltimore, now offers the Calypso® System to provide accurate, precise, real-time tumor tracking for cancer patients undergoing external beam radiation therapy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nina Yang, MD Po Box 568, Cornelius, OR 97113-0568 Ph: (503) 352-8657 | Nina Yang, MD 115 Ne May Ln, Mcminnville, OR 97128-9272 Ph: (503) 472-1338 |
News Archive
A team of Australian scientists has discovered a new type of cell in the immune system. The new cell type, a kind of white blood cell, belongs to a family of T-cells that play a critical role in protection against infectious disease.
Onyx Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted fast track designation for carfilzomib, a next generation proteasome inhibitor for the potential treatment of patients with relapsed and refractory multiple myeloma.
Animals that reproduce asexually by somatic cloning have special mechanisms that delay ageing provide exceptionally good health. Scientists at the University of Gothenburg have shown how colony-forming ascidians can activate the enzyme telomerase, which protects DNA. This enzyme is more active also in humans who attain an advanced age.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced today that the University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated cancer center in Baltimore, now offers the Calypso® System to provide accurate, precise, real-time tumor tracking for cancer patients undergoing external beam radiation therapy.
› Verified 7 days ago
Jan Radzik, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 349 Se Baker St, Mcminnville, OR 97128 Phone: 503-472-9438 Fax: 503-472-9439 | |
Dr. Jennifer Elaine Mueller, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 Ne May Ln, Mcminnville, OR 97128 Phone: 503-472-1338 Fax: 503-434-8597 | |
Dr. Klaus Martin, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 310 Southeast Baker Street, Mcminnville, OR 97128 Phone: 503-472-8433 Fax: 503-472-8679 | |
John D Nelson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 821 Ne Highway 99w Ste A, Mcminnville, OR 97128 Phone: 503-472-4649 Fax: 503-434-1679 | |
Marion C Hull, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 Ne May Ln, Mcminnville, OR 97128 Phone: 503-883-4700 Fax: 503-883-4764 | |
Brandi Acacia Mendonca, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2163 Nw 2nd St, Mcminnville, OR 97128 Phone: 503-472-4197 Fax: 503-434-2886 | |
Sunisa Chanyaputhipong, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 Ne May Ln, Mcminnville, OR 97128 Phone: 503-472-1338 Fax: 503-434-8597 |